FEMAL Trademark

Trademark Overview

On Friday, May 12, 2023, a trademark application was filed for FEMAL with the United States Patent and Trademark Office. The USPTO has given the FEMAL trademark a serial number of 79371094. The federal status of this trademark filing is REGISTERED as of Tuesday, October 8, 2024. This trademark is owned by S.A.R.L. AXEEN PHARMA. The FEMAL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical, natural remedy, and naturopathic remedy preparations in the form of tablets or tonics for medical use for menopausal symptoms; pharmaceutical preparations for treating premenstrual syndrome; prescription and non-prescription pharmaceuticals for menopausal symptoms
femal

General Information

Serial Number79371094
Word MarkFEMAL
Filing DateFriday, May 12, 2023
Status700 - REGISTERED
Status DateTuesday, October 8, 2024
Registration Number7525647
Registration DateTuesday, October 8, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 23, 2024

Trademark Statements

Goods and ServicesPharmaceutical, natural remedy, and naturopathic remedy preparations in the form of tablets or tonics for medical use for menopausal symptoms; pharmaceutical preparations for treating premenstrual syndrome; prescription and non-prescription pharmaceuticals for menopausal symptoms

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 13, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameS.A.M. AXEEN PHARMA
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressMC
Party NameS.A.R.L. AXEEN PHARMA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressMC
Party NameS.A.R.L. AXEEN PHARMA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressMC
Party NameS.A.R.L. AXEEN PHARMA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressMC

Trademark Events

Event DateEvent Description
Sunday, June 11, 2023LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, June 1, 2023SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Tuesday, June 13, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, June 17, 2023APPLICATION FILING RECEIPT MAILED
Thursday, December 21, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, December 21, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, December 21, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 21, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 21, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 21, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 7, 2024ASSIGNED TO EXAMINER
Wednesday, February 7, 2024NON-FINAL ACTION WRITTEN
Wednesday, February 28, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, May 17, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 8, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, February 28, 2024REFUSAL PROCESSED BY MPU
Tuesday, March 26, 2024REFUSAL PROCESSED BY IB
Friday, May 17, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 17, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 14, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 8, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, October 8, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, November 28, 2024CHANGE OF NAME/ADDRESS REC'D FROM IB
Wednesday, January 8, 2025FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 18, 2025FINAL DISPOSITION NOTICE SENT TO IB
Friday, April 4, 2025FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, March 18, 2025FINAL DISPOSITION PROCESSED
Tuesday, July 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

femal pharmaceutical menopausal symptoms preparations remedy prescription pharmaceuticals treating premenstrual syndrome